Advertisement

Late-Onset Combined Immunodeficiencies (LOCID)

  • Eduardo López-GranadosEmail author
Chapter
Part of the Rare Diseases of the Immune System book series (RDIS)

Abstract

The term common variable immunodeficiencies (CVIDs) is applied to a heterogeneous group of primary immunodeficiencies with hypogammaglobulinemia and defective B cell maturation or specific antibody formation. This diagnosis has evolved since first coined in 1971, based on proposed and subsequently revised clinical and immunological criteria. The genetic base of this condition is poorly defined, and only 15–30% of cases seem to be in relation with clear monogenic inheritance. Clinically, CVID can present with infections only or with other disease-related complications. Although it is accepted that CVID could arise as consequence of a B cell intrinsic defect, a certain component of T cell deficiency has been largely appreciated. Therefore, several refinements of the CVID definition and criteria have been proposed trying to exclude from this diagnosis late-onset combined immunodeficiencies (LOCID) that require proper diagnostic and clinical management approaches. This chapter tries to summarize the evolving concepts around the LOCID vs. CVID dilemma and the current perspective.

Keywords

Common variable immunodeficiency disorders (CVIDs) Late-onset combined immunodeficiency (LOCID) Opportunistic infection CD4+ T cell 

References

  1. 1.
    Fudenberg H, Good RA, Goodman HC, et al. Primary immunodeficiencies: report of a World Health Organization committee. Pediatrics. 1971;47:927–46.PubMedGoogle Scholar
  2. 2.
    Cooper MD, Faulk WP, Fudenberg HH, Good RA, Hitzig W, Kunkel H, et al. Classification of primary immunodeficiencies. N Engl J Med. 1973;288:966–7.CrossRefGoogle Scholar
  3. 3.
    Saiki O, Ralph P, Cunningham-Rundles C, Good RA. Three distinct stages of B-cell defects in common varied immunodeficiency. Proc Natl Acad Sci U S A. 1982;79:6008–12.CrossRefGoogle Scholar
  4. 4.
    Bryant A, Calver NC, Toubi E, et al. Classification of patients with common variable immunodeficiency by B cell secretion of IgM and IgG in response to anti-IgM and interleukin-2. Clin Immunol Immunopathol. 1990;56:239–48.CrossRefGoogle Scholar
  5. 5.
    Conley ME, Notarangelo LD, Etzioni A. Diagnostic criteria for primary immunodeficiencies: representing PAGID (Pan-American Group for Immunodeficiency) and ESID (European Society for Immunodeficiencies). Clin Immunol. 1999;93:190–7.CrossRefGoogle Scholar
  6. 6.
    Cunningham-Rundles C, Bodian C. Common variable immunodeficiency: clinical and immunological features of 248 patients. Clin Immunol. 1999;92:34–48.CrossRefGoogle Scholar
  7. 7.
    Chapel H, Lucas M, Lee M, et al. Common variable immunodeficiency disorders: division into distinct clinical phenotypes. Blood. 2008;112:277–86.CrossRefGoogle Scholar
  8. 8.
    Chapel H, Lucas M, Patel S, et al. Confirmation and improvement of criteria for clinical phenotyping in common variable immunodeficiency disorders in replicate cohorts. J Allergy Clin Immunol. 2012;130:1197–1198.e9.CrossRefGoogle Scholar
  9. 9.
    Bayry J, Hermine O, Webster DA, Lévy Y, Kaveri SV. Common variable immunodeficiency: the immune system in chaos. Trends Mol Med. 2005;11:370–6.CrossRefGoogle Scholar
  10. 10.
    Goldacker S, Warnatz K. Tackling the heterogeneity of CVID. Curr Opin Allergy Clin Immunol. 2005;5:504–9.CrossRefGoogle Scholar
  11. 11.
    Serrano D, et al. Characterization of the T cell receptor repertoire in patients with common variable immunodeficiency: oligoclonal expansion of CD8+ T cells. Clin Immunol. 2000;97:248–58.CrossRefGoogle Scholar
  12. 12.
    Guazzi V, et al. Assessment of thymic output in common variable immunodeficiency patients by evaluation of T cell receptor excision circles. Clin Exp Immunol. 2002;129:346–53.CrossRefGoogle Scholar
  13. 13.
    Pirovano S, et al. Impaired thymic output and restricted T-cell repertoire in two infants with immunodeficiency and early-onset generalized dermatitis. Immunol Lett. 2003;86:93–7.CrossRefGoogle Scholar
  14. 14.
    Isgro A, et al. Bone marrow clonogenic capability, cytokine production, and thymic output in patients with common variable immunodeficiency. J Immunol. 2005;174:5074–81.CrossRefGoogle Scholar
  15. 15.
    Boncristiano M, et al. Defective recruitment and activation of ZAP-70 in common variable immunodeficiency patients with T cell defects. Eur J Immunol. 2000;30:2632–8.CrossRefGoogle Scholar
  16. 16.
    Paccani SR, et al. Defective VAV expression and impaired F-actin reorganization in a subset of common variable immunodeficiency patients with T-cell defects. Blood. 2005;106(2):626–34.CrossRefGoogle Scholar
  17. 17.
    Di Renzo M, et al. Enhanced apoptosis of T cells in common variable immunodeficiency (CVID): role of defective CD28 costimulation. Clin Exp Immunol. 2000;120:503–11.CrossRefGoogle Scholar
  18. 18.
    Di Renzo M, et al. Enhanced T cell apoptosis in common variable immunodeficiency: negative role of the fas/fas ligand system and of the Bcl-2 family proteins and possible role of TNF-RS. Clin Exp Immunol. 2001;125:117–22.CrossRefGoogle Scholar
  19. 19.
    Sneller MC, Strober W. Abnormalities of lymphokine gene expression in patients with common variable immunodeficiency. J Immunol. 1990;144:3762–9.PubMedGoogle Scholar
  20. 20.
    Farrington M, et al. CD40 ligand expression is defective in a subset of patients with common variable immunodeficiency. Proc Natl Acad Sci U S A. 1994;91:1099–103.CrossRefGoogle Scholar
  21. 21.
    Fischer MB, et al. A defect in the early phase of T-cell receptor mediated T-cell activation in patients with common variable immunodeficiency. Blood. 1994;84:4234–41.PubMedGoogle Scholar
  22. 22.
    Majolini MB, et al. Uncoupling of T-cell antigen receptor and downstream protein tyrosine kinases in common variable immunodeficiency. Clin Immunol Immunopathol. 1997;84:98–102.CrossRefGoogle Scholar
  23. 23.
    Holm AM, et al. Abnormal interleukin-7 function in common variable immunodeficiency. Blood. 2005;105(7):2887–90.CrossRefGoogle Scholar
  24. 24.
    Farrant J, Spickett G, Matamoros N, et al. Study of B and T cell phenotypes in blood from patients with common variable immunodeficiency (CVID). Immunodeficiency. 1994;5:159–69.PubMedGoogle Scholar
  25. 25.
    Oksenhendler E, Gerard L, Fieschi C, et al. Infections in 252 patients with common variable immunodeficiency. Clin Infect Dis. 2008;46:1547–54.CrossRefGoogle Scholar
  26. 26.
    Grimbacher B, Hutloff A, Schlesier M, et al. Homozygous loss of ICOS is associated with adult-onset common variable immunodeficiency. Nat Immunol. 2003;4:261–8.CrossRefGoogle Scholar
  27. 27.
    Warnatz K, Denz A, Drager R, Braun M, Groth C, Wolff-Vorbeck G, Eibel H, Schlesier M, Peter HH. Severe deficiency of switched memory B cells (CD27_IgM_IgD_) in subgroups of patients with common variable immunodeficiency: a new approach to classify a heterogeneous disease. Blood. 2002;99:1544–51.CrossRefGoogle Scholar
  28. 28.
    Piqueras B, Lavenu-Bombled C, Galicier L, Bergeron-van der Cruyssen F, Mouthon L, Chevret S, Debre P, Schmitt C, Oksenhendler E. Common variable immunodeficiency patient classification based on impaired B cell memory differentiation correlates with clinical aspects. J Clin Immunol. 2003;23:385–400.CrossRefGoogle Scholar
  29. 29.
    Wehr C, Kivioja T, Schmitt C, Ferry B, Witte T, Eren E, Vlkova M, Hernandez M, Detkova D, Bos PR, Poerksen G, von Bernuth H, Baumann U, Goldacker S, Gutenberger S, Schlesier M, Bergeron-van der Cruyssen F, Le Garff M, Debré P, Jacobs R, Jones J, Bateman E, Litzman J, van Hagen PM, Plebani A, Schmidt RE, Thon V, Quinti I, Espanol T, Webster AD, Chapel H, Vihinen M, Oksenhendler E, Peter HH, Warnatz K. The EUROclass trial: defining subgroups in common variable immunodeficiency. Blood. 2008;111(1):77–85.CrossRefGoogle Scholar
  30. 30.
    Giovannetti A, Pierdominici M, Mazzetta F, et al. Unravelling the complexity of T cell abnormalities in common variable immunodeficiency. J Immunol. 2007;178:3932–43.CrossRefGoogle Scholar
  31. 31.
    Notarangelo LD, Fischer A, Geha RS, Casanova JL, Chapel H, Conley ME, et al. Primary immunodeficiencies: 2009 update. J Allergy Clin Immunol. 2009;124:1161–78.CrossRefGoogle Scholar
  32. 32.
    Malphettes M, Gérard L, Carmagnat M, Mouillot G, Vince N, Boutboul D, Bérezné A, Nove-Josserand R, Lemoing V, Tetu L, Viallard JF, Bonnotte B, Pavic M, Haroche J, Larroche C, Brouet JC, Fermand JP, Rabian C, Fieschi C, Oksenhendler E, DEFI Study Group. Late-onset combined immune deficiency: a subset of common variable immunodeficiency with severe T cell defect. Clin Infect Dis. 2009;49(9):1329–38.CrossRefGoogle Scholar
  33. 33.
    Centers for Disease Control and Prevention. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. JAMA. 1993;269:729–30.CrossRefGoogle Scholar
  34. 34.
    Fleischman A, Hershfield MS, Toutain S, et al. Adenosine deaminase deficiency and purine nucleoside phosphorylase deficiency in common variable immunodeficiency. Clin Diagn Lab Immunol. 1998;5:399–400.PubMedPubMedCentralGoogle Scholar
  35. 35.
    Schuetz C, Huck K, Gudowius S, et al. An immunodeficiency disease with RAG mutations and granulomas. N Engl J Med. 2008;358:2030–8.CrossRefGoogle Scholar
  36. 36.
    Aslam A, Chapel H. Dissecting the group of common variable immunodeficiency disorders. Clin Infect Dis. 2009;49(9):1339–40.CrossRefGoogle Scholar
  37. 37.
    Bateman EA, Ayers L, Sadler R, Lucas M, Roberts C, Woods A, Packwood K, Burden J, Harrison D, Kaenzig N, Lee M, Chapel HM, Ferry BL. T cell phenotypes in patients with common variable immunodeficiency disorders: associations with clinical phenotypes in comparison with other groups with recurrent infections. Clin Exp Immunol. 2012;170(2):202–11.CrossRefGoogle Scholar
  38. 38.
    Bertinchamp R, Gérard L, Boutboul D, Malphettes M, Fieschi C, Oksenhendler E, DEFI Study Group. Exclusion of patients with a severe T-cell defect improves the definition of common variable immunodeficiency. J Allergy Clin Immunol Pract. 2016;4(6):1147–57.CrossRefGoogle Scholar
  39. 39.
    Abolhassani H, Cheraghi T, Rezaei N, Aghamohammadi A, Hammarström L. Common variable immunodeficiency or late-onset combined immunodeficiency: a new hypomorphic JAK3 patient and review of the literature. J Investig Allergol Clin Immunol. 2015;25(3):218–20.PubMedGoogle Scholar
  40. 40.
    Abolhassani H, Wang N, Aghamohammadi A, Rezaei N, Lee YN, Frugoni F, Notarangelo LD, Pan-Hammarström Q, Hammarström L. A hypomorphic recombination-activating gene 1 (RAG1) mutation resulting in a phenotype resembling common variable immunodeficiency. J Allergy Clin Immunol. 2014;134(6):1375–80.CrossRefGoogle Scholar
  41. 41.
    Buchbinder D, Baker R, Lee YN, Ravell J, Zhang Y, McElwee J, Nugent D, Coonrod EM, Durtschi JD, Augustine NH, Voelkerding KV, Csomos K, Rosen L, Browne S, Walter JE, Notarangelo LD, Hill HR, Kumánovics A. Identification of patients with RAG mutations previously diagnosed with common variable immunodeficiency disorders. J Clin Immunol. 2015;35(2):119–24.CrossRefGoogle Scholar
  42. 42.
    Okuno Y, Hoshino A, Muramatsu H, Kawashima N, Wang X, Yoshida K, Wada T, Gunji M, Toma T, Kato T, Shiraishi Y, Iwata A, Hori T, Kitoh T, Chiba K, Tanaka H, Sanada M, Takahashi Y, Nonoyama S, Ito M, Miyano S, Ogawa S, Kojima S, Kanegane H. Late-onset combined immunodeficiency with a novel IL2RG mutation and probable revertant somatic mosaicism. J Clin Immunol. 2015;35(7):610–4.CrossRefGoogle Scholar
  43. 43.
    van Schouwenburg PA, Davenport EE, Kienzler A-K, Marwah I, Wright B, Lucas M, et al. Application of whole genome and RNA sequencing to investigate the genomic landscape of common variable immunodeficiency disorders. Clin Immunol. 2015;160:301–14.CrossRefGoogle Scholar
  44. 44.
    Maffucci P, Filion CA, Boisson B, Itan Y, Shang L, Casanova J-L, et al. Genetic diagnosis using whole exome sequencing in common variable immunodeficiency. Front Immunol. 2016;7:220.CrossRefGoogle Scholar
  45. 45.
    Kienzler A-K, Hargreaves CE, Patel SY. The role of genomics in common variable immunodeficiency disorders. Clin Exp Immunol. 2017;188:326–32.CrossRefGoogle Scholar
  46. 46.
    Ameratunga R, Lehnert K, Woon ST, Gillis D, Bryant VL, Slade CA, Steele R. Diagnosing common variable immunodeficiency disorder in the era of genome sequencing. Clin Rev Allergy Immunol. 2018;54(2):261–8.CrossRefGoogle Scholar
  47. 47.
    Wehr C, Gennery AR, Lindemans C, Schulz A, Hoenig M, Marks R, Recher M, Gruhn B, Holbro A, Heijnen I, Meyer D, Grigoleit G, Einsele H, Baumann U, Witte T, Sykora KW, Goldacker S, Regairaz L, Aksoylar S, Ardeniz Ö, Zecca M, Zdziarski P, Meyts I, Matthes-Martin S, Imai K, Kamae C, Fielding A, Seneviratne S, Mahlaoui N, Slatter MA, Güngör T, Arkwright PD, van Montfrans J, Sullivan KE, Grimbacher B, Cant A, Peter HH, Finke J, Gaspar HB, Warnatz K, Rizzi M, Inborn Errors Working Party of the European Society for Blood and Marrow Transplantation and the European Society for Immunodeficiency. Multicenter experience in hematopoietic stem cell transplantation for serious complications of common variable immunodeficiency. J Allergy Clin Immunol. 2015;135(4):988–97.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  1. 1.Coordinador del Servicio de InmunologíaHospital Universitario La Paz-IdiPAZMadridSpain

Personalised recommendations